Ion channels and transporters in cancer. 3. Ion channels in the tumor cell-microenvironment cross talk

American Journal of Physiology - Cell Physiology

Volumn 301, Issue 4, 2011, Pages

  Arcangeli, Annarosa ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Integrins; Ion transporters; Tumor microenvironment; Tumor progression

Indexed keywords

CALCIUM CHANNEL; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; FOCAL ADHESION KINASE; INTEGRIN; INTEGRIN LINKED KINASE; ION CHANNEL; LAMININ; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; POTASSIUM CHANNEL; RGS PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BASEMENT MEMBRANE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CANCER INVASION; CANCER TISSUE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPORT; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; FOCAL ADHESION; GENE EXPRESSION; HUMAN; HYPOXIA; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MELANOMA CELL; MESENCHYMAL STEM CELL; MESENCHYME CELL; MESENCHYMOMA; METASTASIS; MOLECULAR INTERACTION; PANCREAS ADENOCARCINOMA; PANCREATIC STELLATE CELL; PARENCHYMA; PH; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; CELL COMMUNICATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; ION CHANNEL GATING; ION CHANNELS; NEOPLASMS;

EID: 80053217773     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00113.2011     Document Type: Article

References (132)

1. Abdel-Ghany M, Cheng H, Elble RC, Lin H, DiBiasio J, Pauli BU. The interacting binding domains of the beta 4 integrin and calciumactivated chloride channels (CLCAs) in metastasis. J Biol Chem 278: 49406-49416, 2003.
2. Aoki H, Ohnishi H, Hama K, Shinozaki S, Kita H, Yamamoto H, Osawa H, Sato K, Tamada K, Sugano K. Existence of autocrine loop between interleukin-6 and transforming growth factor beta1 in activated rat pancreatic stellate cells. J Cell Biochem 99: 221-228, 2006.
3. Apte MV, Park S, Phillips PA, Santucci N, Goldstein D, Kumar RK, Ramm GA, Buchler M, Friess H, McCarroll JA, Keogh G, Merrett N, Pirola R, Wilson JS. Desmoplastic reaction in pancreatic cancer: Role of pancreatic stellate cells. Pancreas 29: 179-187, 2004.
4. Arcangeli A, Becchetti A. Complex functional interaction between integrin receptors and ion channels. Trends Cell Biol 16: 631-639, 2006.
5. Arcangeli A, Becchetti A. New trends in cancer therapy: targeting ion channels and transporters. Pharmaceuticals 3: 1202-1224, 2010.
6. Arcangeli A, Becchetti A, Mannini A, Mugnai G, De Filippi P, Tarone G, Del Bene MR, Barletta E, Wanke E, Olivotto M. Integrinmediated neurite outgrowth in neuroblastoma cells depends on the activation of potassium channels. J Cell Biol 122: 1131-1143, 1993.
7. Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi S, Becchetti A. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr Med Chem 16: 66-93, 2009.
8. Armstrong T, Packham G, Murphy LB, Bateman AC, Conti JA, Fine DR, Johnson CD, Benyon RC, Iredale JP. Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res 10: 7427-7437, 2004.
9. Artym VV, Petty HR. Molecular proximity of Kv1.3 voltage-gated potassium channels and beta(1)-integrins on the plasma membrane of melanoma cells: effects of cell adherence and channel blockers. J Gen Physiol 120: 29-37, 2002.
10. Barcellos-Hoff MH, Ravani SA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 60: 1254, 2000.
11. Barkan D, Green JE, Chambers AF. Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer 46: 1181-1188, 2010.
12. + current. Proc R Soc Lond B Biol Sci 248: 235-240, 1992.
13. Becchetti A, Pillozzi S, Morini R, Nesti E, Arcangeli A. New insights into the regulation of ion channels by integrins. Int Rev Cell Mol Biol 279: 135-190, 2010.
14. +-ATPase activity influence cell attachment to fibronectin. Am J Physiol Cell Physiol 282: C302-C309, 2002.
15. Bhowmick NA, Moses HL. Tumor-stroma interactions. Curr Opin Genet Dev 15: 97-101, 2005.
16. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 432: 332-337, 2004.
17. Bierie B, Moses HL. Tumour microenvironment: TGFbeta. the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6: 506-520, 2006.
18. Bindea G, Mlecnik B, Fridman WH, Page's F, Galon J. Natural immunity to cancer in humans. Curr Opin Immunol 22: 215-222, 2010.
19. Bissell MJ, Rizki A, Mian IS. Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol 15: 753-762, 2003.
20. + channel Nav1.6 and beta1 subunits in the coordinated regulation of excitability and neurite out-growth. Proc Natl Acad Sci USA 107: 2283-2288, 2010.
21. + channels in cellular migration: regulation of central nervous system development and potentiation of invasive cancers. Neuroscientist 14: 571-583, 2008.
22. Cabodi S, Di Stefano P, del Pilar Camacho Leal M, Tinnirello A, Bisaro B, Morello V, Damiano L, Aramu S, Repetto D, Tornillo G, Defilippi P. Integrins and signal transduction. Adv Exp Med Biol 674: 43-54, 2010.
23. Cahalan MD, Chandy KG. The functional network of ion channels in T lymphocytes. Immunol Rev 231: 59-87, 2009.
24. Cardone RA, Bellizzi A, Busco G, Weinmann EJ, Dell'Aquila ME, Casavola V, Azzariti A, Mangia A, Paradiso A, Reshkin SJ. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38 mediated NHE1 activation and invasion in breast tumor cells. Mol Biol Cell 18: 1768-1780, 2007.
25. Cardone RA, Busco G, Greco MR, Bellizzi A, Accardi R, Cafarelli A, Monterisi S, Carratù P, Casavola V, Paradiso A, Tommasino M, Reshkin SJ. HPV16 E7-dependent transformation activates NHE1 through a PKA-RhoA-induced inhibition of p38alpha. PLoS One 3: e3529, 2008.
26. Cardone RA, Casavola V, Reshkin SJ. The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat Rev Cancer 5: 786-795, 2005.
27. Chandy KG, DeCoursey TE, Cahalan MD, McLaughlin C, Gupta S. Voltage-gated potassium channels are required for human T lymphocyte activation. J Exp Med 160: 369-385, 1984.
28. + channels as targets for specific immunomodulation. Trends Pharmacol Sci 25: 280-289, 2004.
29. Chen C, Young BA, Coleman CS, Pegg AE, Sheppard D. Spermidine/ spermine N1-acetyltransferase specifically binds to the integrin α9 subunit cytoplasmic domain and enhances cell migration. J Cell Biol 167: 161-170, 2004.
30. Cherubini A, Hofmann G, Pillozzi S, Guasti L, Crociani O, Cilia E, Balzi M, Degani S, Di Stefano P, Defilippi P, Wanke E, Becchetti A, Olivotto M, Wymore R, Arcangeli A. HERG1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signalling. Mol Biol Cell 16: 2972-2983, 2005.
31. Cherubini A, Pillozzi S, Hofmann G, Crociani O, Guasti L, Lastraioli E, Polvani S, Masi A, Becchetti A, Wanke E, Olivotto M, Arcangeli A. HERG K+ channels and beta1 integrins interact through the assembly of a macromolecular complex. Ann NY Acad Sci 973: 559-561, 2002.
32. Cichon MA, Degnim AC, Visscher DW, Radisky DC. Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer. J Mammry Gland Biol Neoplasia 15: 389-397, 2010.
33. 2+-mediated monocyte function. Am J Physiol Cell Physiol 283: C990-C1000, 2002.
34. + channels. Adv Exp Med Biol 674: 81-94, 2010.
35. Comoglio PM, Trusolino L. Cancer: the matrix is now in control. Nat Med 11: 1156-1159, 2005.
36. Contois L, Akalu A, Brooks PC. Integrins as "functional hubs" in the regulation of pathological angiogenesis. Semin Cancer Biol 19: 318-328, 2009.
37. Davis MJ, Wu X, Nurkiewicz TR, Kawasaki J, Gui P, Hill MA, Wilson E. Regulation of ion channels by integrins. Cell Biochem Biophys 36: 41-66, 2002.
38. + channels in human T lymphocytes: a role in mitogenesis? Nature 307: 465-468, 1984.
39. de Hart GW, Jin T, McCloskey DE, Pegg AE, Sheppard D. The α9β1 integrin enhances cell migration by polyamine-mediated modulation of an inward-rectifier potassium channel. Proc Natl Acad Sci USA 105: 7188-7193, 2008.
40. de Nardo DG, Andreu P, Coussens LM. Interactions between lymphocytes and myeloid cells regulate pro-versus anti-tumor immunity. Cancer Metastasis Rev 29: 309-316, 2010.
41. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6: 24-37, 2006.
42. 2+ channels. Cell 67: 21-33, 1991.
43. Downie BR, Sánchez A, Knötgen H, Contreras-Jurado C, Gymnopoulos M, Weber C, Stühmer W, Pardo LA. Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors. J Biol Chem 283: 36234-36240, 2008.
44. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659, 1986.
45. Edwards DR, Murphy Cancer G. Proteases invasion and more. Nature 394: 527-528, 1998.
46. Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 18: 884-901, 2010.
47. Faehling M, Kroll J, Föhr KJ, Fellbrich G, Mayr U, Trischler G, Waltenberger J. Essential role of calcium in vascular endothelial growth factor A-induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole. FASEB J 16: 1805-1807, 2002.
48. Farrow B, Rowley D, Dang T, Berger DH. Characterization of tumorderived pancreatic stellate cells. J Surg Res 157: 96-102. 2009.
49. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 9: 669-676, 2003.
50. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29: 15-18, 2002.
51. Ge R, Tai Y, Sun Y, Zhou K, Yang S, Cheng T, Zou Q, Shen F, Wang Y. Critical role of TRPC6 channels in VEGF-mediated angiogenesis. Cancer Lett 283: 43-51, 2009.
52. Giaccia AJ, Schipani E. Role of carcinoma-associated fibroblasts and hypoxia in tumor progression. Curr Top Microbiol Immunol 345: 31-45, 2010.
53. Giancotti FG, Tarone G. Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol 19: 173-206, 2003.
54. Girieca L, Ruegg C. The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 130: 1091-1103, 2008.
55. + currents in two prostatic tumor cell lines: contribution to invasiveness in vitro. FEBS Lett 369: 290-294, 1995.
56. Gregory AD, McGarry Houghton A. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res 71: 2411-2416, 2011.
57. + channels by integrin signaling. Adv Exp Med Biol 674: 69-79, 2010.
58. Hanahan D, Weimberg RA. Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.
59. Harguindey S, Arranz JL, Wahl ML, Orive G, Reshkin SJ. Proton transport inhibitors as potentially selective anticancer drugs. Anticancer Res 29: 2127-2136, 2009.
60. Harris A. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47, 2002.
61. Hoffmann EK, Lambert IH, Pedersen SF. Physiology of cell volume regulation in vertebrates. Physiol Rev 89: 193-277, 2009.
62. + channels activation during β1 integrin-mediated adhesion to fibronectin induces an up-regulation of αvβ3 integrin in the preosteoclastic leukemia cell line FLG 29.1. J Biol Chem 276: 4923-4931, 2001.
63. Hu J, Yuan X, Ko MK, Yin D, Sacapano MR, Wang X, Konda BM, Espinoza A, Prosolovich K, Ong JM, Irvin D, Black KL. Calciumactivated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model. Mol Cancer 6: 22, 2007.
64. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687, 2002.
65. Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, Zavada J, Waheed A, Sly WS, Lerman MI, Stanbridge EJ. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 158: 905-919, 2001.
66. Johansson M, Denardo DG, Coussens LM. Polarized immune responses differentially regulate cancer development. Immunol Rev 222: 145-154, 2008.
67. Johnsen M, Lund LR, Romer J, Almholt K, Dano K. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol 10: 667-671, 1998.
68. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 9: 239-252, 2009.
69. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 6: 392-401, 2006.
70. Kaminski A, Hahne JC, Haddouti EM, Florin A, Wellmann A, Wernert N. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts. Int J Mol Med 18: 941-950, 2006.
71. Kazerounian S, Yee KO, Lawler J. Thrombospondins in cancer. Cell Mol Life Sci 65: 700-712, 2008.
72. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67, 2010.
73. Kiaris H, Chatzistamou I, Kalofoutis C, Koutselini H, Piperi C, Kalofoutis A. Tumour stroma interactions in carcinogenesis: basic aspects and perspectives. Mol Cell Biochem 261: 117-122, 2004.
74. Kim M, Jiang LH, Wilson HL, North RA, Suprenant A. Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J 20: 6347-6358, 2001.
75. Kivela AJ, Parkkila S, Saarnio J, Karttunen TJ, Kivela J, Parkkila AK, Pastorekova S, Pastorek J, Waheed A, Sly WS, Rajaniemi H. Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours. Histochem Cell Biol 114: 197-204, 2000.
76. + channels in human mesenteric artery: a single-cell reverse transcriptase-polymerase chain reaction and electrophysiological study in situ. Circ Res 87: 496-503, 2000.
77. Kohn EC, Alessandro R, Spoonster J, Wersto RP, Liotta LA. Angiogenesis: role of calcium-mediated signal transduction. Proc Natl Acad Sci USA 92: 1307-1311, 1995.
78. Lastraioli E, Guasti L, Crociani O, Polvani S, Hofmann G, Witchel H, Bencini L, Calistri M, Messerini L, Scatizzi M, Moretti R, Wanke E, Olivotto M, Mugnai G, Arcangeli A. herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells. Cancer Res 64: 606-611, 2004.
79. Leavesley DI, Schwartz MA, Rosenfeld M, Cheresh DA. Integrin beta-1 and beta-3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 121: 163-170, 1993.
80. + and opening of voltagegated potassium channels activate T cell integrin function: physical and functional association between Kv1.3 channels and beta1 integrins. J Exp Med 191: 1167-1176, 2000.
81. Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 101: 805-815, 2007.
82. Li Z, Manna P, Kobayashi H, Spilde T, Bhatia A, Preuett B, Prasadan K, Hembree M, Gittes GK. Multifaceted pancreatic mesenchymal control of epitelial lineage selection. Dev Biol 269: 252, 2004.
83. Liao D, Johnson RS. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 26: 281-290, 2007.
84. Loewen M, Forsyth GW. Structure and function of CLCA proteins. Physiol Rev 85: 1061-1092, 2005.
85. Löhr M, Schmidt C, Ringel J, Kluth M, Müller P, Nizze H, Jesnowski R. Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Res 61: 550-555, 2001.
86. Lopez-Castejon G, Theaker J, Pelegrin P, Clifton AD, Braddock M, Surprenant A. P2X7 Receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases. J Immunol 185: 2611-2619, 2010.
87. Luzzi KJ, Varghese HJ, MacDonald IC, Schmidt EE, Kohn EC, Morris VL, Marshall KE, Chambers AF, Groom AC. Inhibition of angiogenesis in liver metastases by carboxyamidotriazole (CAI). Angiogenesis 2: 373-379, 1998.
88. Mahadevan D, Von Hoff DD. Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther 6: 1186-1197, 2007.
89. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 454: 436-444, 2008.
90. Mantovani A. Molecular pathways linking inflammation and cancer. Curr Mol Med 10: 369-373, 2010.
91. Masi A, Becchetti A, Restano-Cassulini R, Polvani S, Hofmann G, Buccoliero AM, Paglierani M, Pollo B, Taddei GL, Gallina P, Di Lorenzo M, Franceschetti S, Wanke E, Arcangeli A. hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines. Br J Cancer 93: 781-792, 2005.
92. Menegazzi R, Busetto S, Cramer R, Dri P, Patriarca P. Role of intracellular chloride in the reversible activation of neutrophil b2 integrins: a lesson from TNF stimulation. J Immunol 165: 4606-4614, 2000.
93. Menegazzi R, Busetto S, Decleva E, Cramer R, Dri P, Patriarca P. Triggering of chloride ion efflux from human neutrophils as a novel function of leukocyte beta 2 integrins: relationship with spreading and activation of the respiratory burst. J Immunol 162: 423-34, 1999.
94. Miranti CK, Brugge JS. Sensing the environment. A historical perspective of integrin signal transduction. Nat Cell Biol 4: E83-E90, 2002.
95. Nagy JA, Chang SH, Shih SC, Dvorak AM, Dvorak HF. Heterogeneity of the tumor vasculature. Semin Thromb Hemost 36: 321-331, 2010.
96. Nichols CG, Lopatin AN. Inward rectifier potassium channels. Annu Rev Physiol 59:171-191, 1997.
97. Onkal R, Djamgoz MBA. Molecular pharmacology of voltage-gated sodium channel expression in metastatic disease: Clinical potential of neonatal Nav1.5 in breast cancer. Eur J Pharmacol 625: 206-219, 2009.
98. + channel (Kv1.3) in human T cells. Biochem Biophys Res Commun 391: 909-914, 2010.
99. Papadopoulos MC, Saadoun S, Verkman AS. Aquaporins and cell migration. Pflügers Arch 456: 693-700, 2008.
100. + channel subunits in development and disease. Neurosci Letters 486: 53-59, 2010.
101. Pegg AE. Spermidine/spermine-N(1)-acetyltransferase: a key metabolic regulator. Am J Physiol Endocrinol Metab 294: E995-E1010, 2008.
102. Pietras K, Ostman A. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 316: 1324-1331, 2010.
103. Pillozzi S, Arcangeli A. Physical and functional interaction between integrins and hERG1 channels in cancer cells. Adv Exp Med Biol 674: 55-67, 2010.
104. + channel form a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome. Blood 110: 1238-1250, 2007.
105. Pillozzi S, Masselli M, DeLorenzo E, Accordi B, Cilia E, Crociani O, Amedei A, Veltroni M, D'Amico M, Basso G, Becchetti A, Campana D, Arcangeli A. Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. Blood 117:902-914, 2011.
106. Prevarskaya N, Skryma R, Shuba Y. Ion channels and the hallmarks of cancer. Trends Mol Med 16: 107-121, 2010.
107. Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 4: 38, 2006.
108. Räsänen K, Vaheri A. Activation of fibroblasts in cancer stroma. Exp Cell Res 316: 2713-2722, 2010.
109. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. Cell migration: integrating signals from front to back. Science 302: 1704-1709, 2003.
110. Rouslahti E. Specialization of tumour vasculature. Nat Rev Cancer 2: 83-90, 2002.
111. Ruoslahti E, Bhatia SN, Sailor MJ. Targeting of drugs and nanoparticles to tumors. J Cell Biol 188: 759-768, 2010.
112. Sato N, Maehara N, Goggins M. Gene expression profiling of tumorstromal interactions between pancreatic cancer cells and stromal fibroblasts. Cancer Res 64: 6950-6956, 2004.
113. Schwab A, Hanley P, Fabian A, Stock C. Potassium channels keep mobile cells on the go. Physiology 23: 212-220, 2008.
114. Schwab A, Nechyporuk-Zloy V, Fabian A. Cells move when ions and water flow. Pflügers Arch 453: 421-432, 2007.
115. Schwartz MA. Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium. J Cell Biol 120: 1003-1010, 1993.
116. Semenza GL. Tumor metabolism: cancer cells give and take lactate. J Clin Invest 118: 3835-3837, 2008.
117. Semenza GL. Defining the role of hypoxia-inducible-factor 1 in cancer biology and therapeutics. Oncogene 29: 625-634, 2010.
118. Shinohara ET, Maity A. Increasing sensitivity to radiotherapy and chemotherapy by using novel biological agents that alter the tumor microenvironment. Curr Mol Med 9: 1034-1045, 2009.
119. Shimoda M, Mellody KT, Orimo A. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin Cell Dev Biol 21: 19-25, 2010.
120. Sunderland WJ, Son YJ, Miner JH, Sanes JR, Carlson SS. The presynaptic calcium channel is part of a transmembrane complex linking a synaptic laminin (α4 β2 γ1) with non-erythroid spectrin. J Neurosci 20: 1009-1019, 2000.
121. Swietach P, Patiar S, Supuran CT, Harris AL, Vaughan-Jones RD. The role of carbonic anhydrase 9 in regulating extracellular and intracellular pH in three-dimensional tumor cell growth. J Biol Chem 284: 20299-20310, 2009.
122. Swietach P, Vaughan-Jones RD, Harris AL. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 26: 299-310. 66, 2007.
123. Thodeti CK, Matthews B, Ravi A, Mammoto A, Ghosh K, Bracha AL, Ingber DE. TRPV4 channels mediate cyclic strain-induced endothelial cell reorientation through integrin to integrin signalling. Circ Res 104: 1123-1130, 2009.
124. Tominaga T, Barber DL. Na-H exchange acts downstream of RhoA to regulate integrin-induced cell adhesion and spreading. Mol Biol Cell 9: 2287-2303, 1998.
125. Vandenberg CA. Integrins step up the pace of cell migration through polyamines and potassium channels. Proc Natl Acad Sci USA 105: 7109-7110, 2008.
126. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033, 2009.
127. Wang Z, Li Y, Sarkar FH. Signaling mechanism(s) of reactive oxygen species in Epithelial-Mesenchymal Transition reminiscent of cancer stem cells in tumor progression. Curr Stem Cell Res Ther 5:74-80, 2010.
128. Warburg O. On respiratory impairment in cancer cells. Science 124: 269-270, 1956.
129. Wei JF, Wei L, Zhou X, Lu ZY, Francis K, Hu XY, Liu Y, Xiong WC, Zhang X, Banik NL, Zheng SS, Yu Kv-FAK SP. Formation of complex as a mechanism of FAK activation, cell polarization and enhanced motility. J Cell Physiol 217: 544-557, 2008.
130. + channels inhibits proliferation of human endothelial cells induced by basic fibroblast growth factor. J Vasc Res 35: 363-371, 1998.
131. Wu X, Davis GE, Meininger GA, Wilson E, Davis MJ. Regulation of the L-type calcium channel by alpha 5 beta 1 integrin requires signaling between focal adhesion proteins. J Biol Chem 276: 30285-30292, 2001.
132. Wu X, Mogford JE, Platts SH, Davis GE, Meininger GA, Davis MJ. Modulation of calcium current in arteriolar smooth muscle by alphav beta3 and alpha5 beta1 integrin ligands. J Cell Biol 143: 241-252, 1998.